These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 10976477)
1. The role of enhanced Doppler ultrasound in differentiation of benign vs. malignant scar lesion after breast surgery for malignancy. Bäz E; Madjar H; Reuss C; Vetter M; Hackelöer B; Holz K Ultrasound Obstet Gynecol; 2000 May; 15(5):377-82. PubMed ID: 10976477 [TBL] [Abstract][Full Text] [Related]
2. [Scar or recurrence--comparison of MRI and color-coded ultrasound with echo signal amplifiers]. Aichinger U; Schulz-Wendtland R; Krämer S; Lell M; Bautz W Rofo; 2002 Nov; 174(11):1395-401. PubMed ID: 12424666 [TBL] [Abstract][Full Text] [Related]
3. [Breast cancer recurrence versus scar. Ultrasonographic differentiation using Levovist as the contrast medium]. Stuhrmann M; Schwarz T; Schietzel M Ultraschall Med; 2001 Feb; 22(1):2-6. PubMed ID: 11253551 [TBL] [Abstract][Full Text] [Related]
4. Tumor vascularity of breast lesions: potentials and limits of contrast-enhanced Doppler sonography. Stuhrmann M; Aronius R; Schietzel M AJR Am J Roentgenol; 2000 Dec; 175(6):1585-9. PubMed ID: 11090380 [TBL] [Abstract][Full Text] [Related]
5. The use of breast ultrasound color Doppler vascular pattern morphology improves diagnostic sensitivity with minimal change in specificity. Svensson WE; Pandian AJ; Hashimoto H Ultraschall Med; 2010 Oct; 31(5):466-74. PubMed ID: 20094978 [TBL] [Abstract][Full Text] [Related]
6. Value of contrast-enhanced power Doppler sonography using a microbubble echo-enhancing agent in evaluation of small breast lesions. Kook SH; Kwag HJ J Clin Ultrasound; 2003 Jun; 31(5):227-38. PubMed ID: 12767017 [TBL] [Abstract][Full Text] [Related]
7. [What is the role of Doppler color sonography associated with echo-signal enhancing levovist in complementary breast diagnosis?]. Grüner C; Schönwälder A; Schulz-Wendtland R; Lang N; Bautz W Aktuelle Radiol; 1998 Mar; 8(2):58-62. PubMed ID: 9592578 [TBL] [Abstract][Full Text] [Related]
8. [Vascularization of breast tumors: use of ultrasound contrast medium in evaluating tumor entity. Preliminary results]. Stuhrmann M; Aronius R; Roefke C; Schietzel M Rofo; 1998 Oct; 169(4):360-4. PubMed ID: 9819647 [TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced power Doppler sonography in breast lesions: effect on differential diagnosis after mammography and gray scale sonography. Zdemir A; Kiliç K; Ozdemir H; Yücel C; Andaç S; Colak M J Ultrasound Med; 2004 Feb; 23(2):183-95; quiz 196-7. PubMed ID: 14992355 [TBL] [Abstract][Full Text] [Related]
10. [Prospective analysis of quantification of contrast media enhanced power Doppler sonography of equivocal breast lesions]. Pudszuhn A; Marx Ch; Malich A; Fleck M; Schneider A; Kaiser WA Rofo; 2003 Apr; 175(4):495-501. PubMed ID: 12677504 [TBL] [Abstract][Full Text] [Related]
11. [Contrast enhanced power Doppler and color Doppler ultrasound in breast masses: Efficiency in diagnosis and contributions to differential diagnosis]. Algül A; Balci P; Seçil M; Canda T Tani Girisim Radyol; 2003 Jun; 9(2):199-206. PubMed ID: 14661490 [TBL] [Abstract][Full Text] [Related]
12. Color Doppler sonography in the evaluation of palpable breast masses. McNicholas MM; Mercer PM; Miller JC; McDermott EW; O'Higgins NJ; MacErlean DP AJR Am J Roentgenol; 1993 Oct; 161(4):765-71. PubMed ID: 8372754 [TBL] [Abstract][Full Text] [Related]
13. [Ultrasonography contrast media Levovist and power Doppler in the study of the breast. Methodology, vascular morphology and automatic enhancement quantification with wash-in and wash-out curves]. Menna S; Di Virgilio MR; Burke P Radiol Med; 1999 Jun; 97(6):472-8. PubMed ID: 10478204 [TBL] [Abstract][Full Text] [Related]
14. [Analysis of vascularity in breast tumors--comparison of high frequency ultrasound and contrast-enhanced color harmonic imaging]. Schröder RJ; Bostanjoglo M; Hidajat N; Rademaker J; Röttgen R; Mäurer J; Felix R Rofo; 2002 Sep; 174(9):1132-41. PubMed ID: 12221572 [TBL] [Abstract][Full Text] [Related]
15. Comparing contrast-enhanced color flow imaging and pathological measures of breast lesion vascularity. Forsberg F; Kuruvilla B; Pascua MB; Chaudhari MH; Merton DA; Palazzo JP; Goldberg BB Ultrasound Med Biol; 2008 Sep; 34(9):1365-72. PubMed ID: 18436369 [TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced ultrasound is helpful in the differentiation of malignant and benign breast lesions. Zhao H; Xu R; Ouyang Q; Chen L; Dong B; Huihua Y Eur J Radiol; 2010 Feb; 73(2):288-93. PubMed ID: 19559551 [TBL] [Abstract][Full Text] [Related]
17. Nonpalpable breast lesions: evaluation with power Doppler US and a microbubble contrast agent-initial experience. Moon WK; Im JG; Noh DY; Han MC Radiology; 2000 Oct; 217(1):240-6. PubMed ID: 11012451 [TBL] [Abstract][Full Text] [Related]
18. Videodensitometry in the examination of focal breast lesions after injection of an ultrasound contrast agent. Blohmer JU; Reinhardt M; Schmalisch G; Lichtenegger W; Hausschild M; Kümmel S; Fischer T; Ohlinger R; Thomas A Anticancer Res; 2006; 26(2C):1691-8. PubMed ID: 16617563 [TBL] [Abstract][Full Text] [Related]
19. Power Doppler and gray-scale sonography standardized by BI-RADS for the differentiation of benign postoperative lesion and local recurrence after breast-conserving therapy. Kubota K; Iwasa H; Aoyama N; Hamada N; Nogami M; Tamura T; Nishioka A; Ogawa Y Oncol Rep; 2011 Dec; 26(6):1357-62. PubMed ID: 21887473 [TBL] [Abstract][Full Text] [Related]
20. Microbubble contrast agent for color Doppler US: effect on breast masses. Work in progress. Kedar RP; Cosgrove D; McCready VR; Bamber JC; Carter ER Radiology; 1996 Mar; 198(3):679-86. PubMed ID: 8628854 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]